These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1952565)

  • 1. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
    Takami M; Takata Y; Matsumoto K; Ono S; Tsukada W
    Ann N Y Acad Sci; 1991; 629():407-9. PubMed ID: 1952565
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase.
    Takami M; Tsukada W
    Pharmacol Res; 1998 Aug; 38(2):133-9. PubMed ID: 9721601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of DP-1904, a novel anti-asthma agent, against antigen-induced constriction and TXB2 release from the isolated guinea-pig lung parenchymal tissue.
    Takami M; Tsukada W
    Pharmacol Res; 1998 Aug; 38(2):141-7. PubMed ID: 9721602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion.
    Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T
    Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
    Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis.
    Yoshida T; Kameda H; Masashi A; Homma M; Ikeda Y
    Adv Exp Med Biol; 1997; 433():113-7. PubMed ID: 9561116
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of inhibition of thromboxane production on the leukotriene D4-mediated bronchoconstriction in the guinea pig.
    Muccitelli RM; Osborn RR; Weichman BM
    Prostaglandins; 1983 Aug; 26(2):197-206. PubMed ID: 6689082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DP-1904, a thromboxane synthetase inhibitor, on antigen- and spasmogen-induced bronchoconstriction in rodents.
    Takami M; Tsukada W
    Eur J Pharmacol; 1999 Feb; 366(2-3):253-9. PubMed ID: 10082207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of thromboxane A2 synthetase inhibitor, DP-1904 on the action of vasoactive substances in guinea pig trachea and lung tissue strips].
    Shimizu K; Kobayashi J; Iwanaga T; Kuratomi Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):339-44. PubMed ID: 2615088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
    Nagao T; Ito M; Nagamatsu T; Suzuki Y
    Eur J Pharmacol; 1994 Jul; 259(3):233-42. PubMed ID: 7982449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endothelin-induced bronchoconstriction by OKY-046, a selective thromboxane A2 synthetase inhibitor, in guinea pigs.
    Nambu F; Yube N; Omawari N; Sawada M; Okegawa T; Kawasaki A; Ikeda S
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():453-6. PubMed ID: 1825581
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma.
    Fukushima C; Shimoda T; Matsuse H; Takao A; Sakai H; Asai S; Kohno S; Hara K
    Ann Allergy Asthma Immunol; 1996 Dec; 77(6):483-7. PubMed ID: 8970439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. III. 4-[2-(5-ethyl-2-thienyl)]-2'-[2-(1-imidazolyl)ethyl]-1(2H)- phthalazinones.
    Yamaguchi M; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1601-4. PubMed ID: 7954911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans.
    Ohnishi A; Ishizaki T; Echizen H; Yasuda K; Fujiwara H; Tanaka T
    Clin Pharmacol Ther; 1992 Apr; 51(4):454-64. PubMed ID: 1563215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indan derivatives.
    Kanao M; Watanabe Y; Kimura Y; Saegusa J; Yamamoto K; Kanno H; Kanaya N; Kubo H; Ashida S; Ishikawa F
    J Med Chem; 1989 Jun; 32(6):1326-34. PubMed ID: 2724303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Yoshida T; Ichikawa Y; Tojo T; Homma M
    Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury.
    Masumura H; Kunitada S; Irie K; Ashida S; Abe Y
    Eur J Pharmacol; 1991 Feb; 193(3):321-7. PubMed ID: 2055246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    Nagao T; Nagamatsu T; Suzuki Y
    Eur J Pharmacol; 1996 Nov; 316(1):73-80. PubMed ID: 8982653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.